Portrett av Kari Helen Simonsen

Career Experience

2008 – Date: Onsagers, European Patent Attorney

2002 – 08: Onsagers, Patent Attorney

2001 – 02: Tandbergs Patentkontor, Patent Attorney

1993 – 01: The Norwegian Industrial Property Office (NIPO), Senior examiner


2023: UPC representative

1986 – 1993: University of Oslo (UiO), Cand.Scient (M.Sc), Biochemistry/Biotechnology


Patent star 2021
Top 250 Women in IP 2021
Managing IP – IP Stars


Norske Patentingeniørers Forening
Norsk Biokjemisk Selskap
NIR (Norsk Forening for Industriell Rettsbeskyttelse)


Norwegian and English

Kari Simonsen is a European Patent Attorney with more than 20 years’ Life Sciences/Pharmaceutical sector IPR experience, specializing in Chemistry, Pharmacy and Bio-technology. She was formerly a Senior Examiner at The Norwegian Industrial Property Office (NIPO). Today, Kari assists clients in drafting and handling patent applications and oppositions, freedom-to-operate evaluations, infringement issues and IP strategy.

In 2023, Kari successfully obtained the University degree on Patent Litigation in Europe at the International Center of Intellectual Property Studies, University of Strasbourg (France). Kari is now registered as a representative before the Unified Patent Court (UPC).

Key Experience

In the last 17 years Kari has acquired extensive experience of Infringement and Validity in numerous pharma sector patent litigation cases in Norway. These include: paroxetine, citalopram, escitalopram, omeprazole, lansoprazole, atorvastatine, alendronate, bicalutamide, donepezil, irbesartan, oxycodone, sildenafil, formoterol/budesonide, and several others.